TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 1 filers reported holding TURNING POINT THERAPEUTICS I in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $151,422,000 | +179.3% | 2,012,250 | -0.3% | 2.74% | +212.2% |
| Q1 2022 | $54,209,000 | -46.0% | 2,018,950 | -4.2% | 0.88% | -32.0% |
| Q4 2021 | $100,478,000 | -35.9% | 2,106,450 | -10.8% | 1.29% | -25.1% |
| Q3 2021 | $156,863,000 | -14.9% | 2,361,327 | 0.0% | 1.72% | -7.5% |
| Q2 2021 | $184,231,000 | -17.5% | 2,361,327 | 0.0% | 1.86% | -10.8% |
| Q1 2021 | $223,358,000 | -33.2% | 2,361,327 | -14.0% | 2.09% | -28.7% |
| Q4 2020 | $334,518,000 | +39.5% | 2,745,327 | 0.0% | 2.93% | -2.9% |
| Q3 2020 | $239,832,000 | +35.3% | 2,745,327 | 0.0% | 3.01% | +20.8% |
| Q2 2020 | $177,321,000 | +44.6% | 2,745,327 | 0.0% | 2.50% | +21.2% |
| Q1 2020 | $122,606,000 | -28.3% | 2,745,327 | 0.0% | 2.06% | -15.6% |
| Q4 2019 | $171,006,000 | +65.7% | 2,745,327 | 0.0% | 2.44% | +24.6% |
| Q3 2019 | $103,224,000 | -1.2% | 2,745,327 | +6.9% | 1.96% | +21.1% |
| Q2 2019 | $104,499,000 | – | 2,567,550 | – | 1.62% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|